1.03k likes | 1.9k Views
2. Instructions. ? Click this arrow to view the next page? Click this arrow to view the previous page Click here to return to the main or submenu. Click the highlighted links for more information on specific topics continue.
E N D
1. Bioadhesive Polymers
By Sheila Aidoo Click here to start
2. 2 Instructions ? Click this arrow to view the next page
? Click this arrow to view the previous page
Click here to return to the main or submenu.
Click the highlighted links for more information on specific
topics
continue
3. 3 Introduction This CAL Package has been developed to give Pharmaceutical science students an introduction to bioadhesive polymers.
The Package also includes information on different examples of bioadhesive polymers and their application in drug delivery systems.
4. 4 ? ? Main Menu What is a Bioadhesive Polymer?
Bioadhesion and Drug Absorption
Bioadhesive Drug Delivery Systems
Types of Bioadhesive Formulations
Targets for Bioadhesive Formulations
Summary
Glossary
Useful links
Quiz
5. 5 What is a bioadhesive polymer? Definition
History
Examples
6. 6 Definition of a Bioadhesive Polymer A polymer is a substance formed by the linkage of a large number of
small molecules known as monomers. A bioadhesive polymer is a
synthetic or natural polymer which binds to biological substrates such as
mucosal membranes. Such polymers are sometimes referred to as
biological ‘glues’ because they are incorporated into drugs to enable the
drugs to bind to their target tissues.
7. 7 Mucosal membranes These are moist membranes that line passageways and structures in the
body that lead to the outside environment such as the mouth, respiratory
tract, gastrointestinal tract, nose and vagina. They secrete a viscous
fluid known as mucus, which acts as a protective barrier and also
lubricates the mucosal membrane. The primary constituent of mucus is a
glycoprotein known as mucin as well as water and inorganic salts.
8. 8 History Bioadhesive drug delivery formulations were introduced in 1947 when gum
tragacanth was mixed with dental adhesive powder. The aim was to deliver
Penicillin into the oral mucosa. This later became Orabase®, a formulation used to
treat mouth ulcers. This product is available as a paste which will stick to the wet
surfaces of the mouth and form a protective film over the mouth ulcer. Orabase
paste contains polymers such as gelatin, pectin and carboxymethylcellulose.
Some examples of Orabase products are shown below
9. 9 Examples of polymers Bioadhesive polymers come from both natural and synthetic sources,
some common examples are highlighted below:
Acacia gum - This natural polymer is a dried gum obtained from the stem and branches of the tree Acacia senegal. It is used as a thickener in pharmaceuticals.
Alginic acid – Is a natural polymer found in the cell walls of brown algae. It is widely used in the manufacture of alginate salts such as sodium alginate which is a constituent of Gaviscon liquid®.
Carbomers – Are polyacrylic acid polymers widely used in the pharmaceutical and cosmetic industries as thickening agents.. Carbomers have a huge advantage in formulation science because they adhere strongly to mucosal membranes without causing irritation, they exhibit low toxicity profiles and are compatible with many drugs.
10. 10 More examples Hydroxypropyl methylcellulose (HPMC) – This polymer is included in preparations used to moisten contact lenses and in oral gels.
Sodium hyaluronate - A high molecular weight biological polymer made of repeating disaccharide units of glucuronic acid and N-acetyl-D - glucosamine. This polymer is used during intraocular surgery to protect the cornea and also acts as a tear substitute in the treatment of dry eyes.
Other examples of polymers include:
- pectin
- polyvinylalcohol (PVA)
- polyvinylpyrrolidone (PVP)
- tragacanth
11. 11 Bioadhesion and Drug Absorption Drug absorption is the process by which a drug leaves its site of administration and
enters the general circulation. A drug has to cross several cell membranes before
reaching its target tissue or organ.
These membranes act as barriers which control the transport of drugs and other
molecules across cells. The general structure of a cell/plasma membrane consists
of a matrix of proteins surrounded by a phospholipid bilayer.
Drugs may cross a cell membrane by passive diffusion, facilitated passive diffusion,
active transport or pinocytosis. Drug absorption is determined by physicochemical
properties of drugs, their formulations (e.g. tablet,capsule,solution) and routes of
administration such as oral, parenteral or rectal.
12. 12 Passive Diffusion Diffusion is the tendency of molecules to spread into an available space. In the
process of passive diffusion the transport of molecules across cell membranes
depends very much on the concentration of the molecule.
Most drug molecules are transported across membranes by diffusion from a region
of high concentration (eg.Gastrointestinal fluids) to one of a lower concentration
such as blood.
Since cell membranes are lipid in nature, lipid
soluble drugs are able to diffuse across the
membrane more rapidly than non-lipid soluble
drugs. Small molecules are also able
to penetrate the membrane more rapidly than
larger ones.
13. 13 Facilitated passive diffusion This is when molecules are transported across membranes and into cells with the
help of carrier proteins. These proteins only interact with certain molecules and
therefore exhibit specificity.
The process of carrier-mediated transport depends on the availability of carriers, this
means that at a particular point during transport the carrier will become saturated.
An example of this type of diffusion is the
transport of glucose from blood.
14. 14 Active Transport Active transport is the movement
of molecules and ions against
their concentration gradients,
from lower to higher
concentrations. This form of
transport requires an input of
energy from cells which is
obtained from ATP (Adenosine
Triphosphate).
15. 15 Pinocytosis Pinocytosis (a form of endocytosis) allows a cell to engulf large
molecules and fluid that may be present in the extracellular region.
The cell membrane folds inwards, encloses the fluid or particle to
be transported and then fuses to form a vesicle.
The vesicle detaches from the
membrane and moves to the
interior of the cell. Pinocytosis
plays a role in the transport of
protein drugs.
16. 16 Bioadhesion and Drug Absorption The adhesion of bioadhesive drugs to mucosal membranes leads to an
increase in the concentration of the drug at its site of action. This means
that a greater amount of drug is available at the specific target site to
cause the desired therapeutic effect.
The concept of using bioadhesive polymers in drug delivery systems is
therefore quite important because it enhances the absorption of drugs.
17. 17 Bioadhesive Drug Delivery Systems In bioadhesive drug delivery systems, the term bioadhesion is used to describe the
bonding or adhesion between a synthetic or natural polymer and soft tissues such
as epithelial cells. The term mucoadhesion is used to describe adhesion interactions
between polymers and mucus or mucosal surfaces.
Mechanisms of bioadhesion
The mechanisms responsible in the formation of bioadhesive bonds are not fully
known, however most research has described bioadhesive bond formation as a
three step process.
Step 1 : Wetting and swelling of polymer
Step 2 : Interpenetration between the polymer chains and the mucosal membrane
Step 3 : Formation of chemical bonds between the entangled chains
18. 18 Bioadhesive Drug Delivery Systems Step 1
The wetting and swelling step occurs when the polymer spreads over the surface of
the biological substrate or mucosal membrane in order to develop an intimate
contact with the substrate. This can be readily achieved for example by placing a
bioadhesive formulation such as a tablet or paste within the oral cavity or vagina.
Bioadhesives are able to adhere to or bond with biological tissues by the help of the
surface tension and forces that exist at the site of adsorption or contact. Swelling of
polymers occur because the components within the polymers have an affinity for
water.
The image below shows swelling of a polymer
19. 19 Bioadhesive Drug Delivery Systems Step 2
The surface of mucosal membranes are composed of high molecular weight
polymers known as glycoproteins. In step 2 of the bioadhesive bond formation, the
bioadhesive polymer chains and the mucosal polymer chains intermingle and
entangle to form semi permeable adhesive bonds. The strength of these bonds
depends on the degree of penetration between the two polymer groups. In order to
form strong adhesive bonds, one polymer group must be soluble in the other and
both polymer types must be of similar chemical structure.
The interpenetration of polymer chains
Bioadhesive
polymer chains
Mucus
polymer chains
20. 20 Bioadhesive Drug delivery Systems Step 3
This step involves the formation of weak chemical bonds between the entangled
polymer chains. The types of bonding formed between the chains include primary
bonds such as covalent bonds and weaker secondary interactions such as van der
Waals Interactions and hydrogen bonds. Both primary and secondary bonds are
exploited in the manufacture of bioadhesive formulations in which strong adhesions
between polymers are formed.
Mechanisms of bioadhesion
Step 3
21. 21 Characteristics of Bioadhesive polymers In order for polymers to adhere to mucosal surfaces or epithelial cell they must
ideally possess certain characteristics:
Flexibility- The flexibility of bioadhesive polymers is important because it controls the extent of the interpenetration between the polymers and mucosal/epithelial surfaces.
Hydrophilicity – Polymers that are hydrophilic in nature are able to form strong
adhesive bonds with mucosal membranes because the mucus layer contains large amounts of water.
Hydrogen bonding – Hydrogen bonding between the entangled polymer chains
forms strong adhesive bonds, therefore the presence of hydrogen bond – forming groups such as OH and COOH groups are vital in large quantities.
High molecular weight – Polymers with a high molecular weight are desirable because they provide more available bonding sites.
Surface tensions – Surface tensions are needed to spread the bioadhesive polymer into the mucosal layer epithelial surface.
22. 22 Types of Bioadhesive Formulations 1.Solid Bioadhesive Formulations: Examples of such formulations are given
below.
Tablets : Dry formulations such as tablets are able to form strong interactions with
mucosal surfaces by attracting water from the mucosal surface. An example is
Buccastem® which is used in the treatment of nausea, vomiting and vertigo. It is
administered to the buccal mucosa (inside of the cheeks).
Inserts: These include ocular inserts such as eye drops and eye gels. An example is
Pilogel® which is used in the treatment of glaucoma (raised pressure in the eye).
Pilogel® contains the bioadhesive agent carbomer 940,which minimises irritation
and prevents the loss of product by keeping the gel in place.
Lozenges: Bioadhesive lozenges containing antibiotics and local anaesthetics can
be used topically to treat conditions affecting the mouth. Research has shown
that bioadhesive lozenges are able to release drugs in a controlled manner by
prolonging the drug release.
23. 23 Types of Bioadhesive Formulations 2. Semi-solid bioadhesive Formulations
Gels :Bioadhesive polymers that are able to form gels include polyacrylic acid which
adheres to mucosal surfaces in a cross-linked form. Gel formulations are used to
target several parts of the body including the eye, vagina and oral cavity. An
advantage of gels is that they are able to form a very close contact with mucosal
membranes and rapidly release drugs at their site of absorption.
Films: Bioadhesive films that are flexible in nature can be used to directly deliver
drugs to specific mucosal membranes. They form a very close contact with
the membrane and are able to deliver an accurate dose of drug to the site of
absorption. An example of a bioadhesive film is Zilactin® which is used in the
treatment of cold sores and mouth ulcers.
24. 24 Types of Bioadhesive Formulations 3.Liquid Bioadhesive Formulations
Viscous liquids: Viscous liquids containing bioadhesive polymers such as
carboxymethyl cellulose may be used to protect mucosal membranes from damage
and irritation. They can also be used to deliver drugs to specific sites. An example is
artificial tears, a carbomer solution used to treat dry eyes.
Gel-forming liquids: These formulations are administered as liquids but undergo a
change in their form in response to conditions such as temperature and pH. Such
formulations are used for the controlled-release of drugs into the eye.
25. 25 Targets for Bioadhesive Formulations Bioadhesive or mucoadhesive
formulations have been targeted to
various anatomical locations to aid drug
delivery and absorption. These
structures possess mucous membranes
which protect the cell from damage.
Drug delivery to each anatomical region
is discussed below.
Table 1 : Sites to which bioadhesive formulations are targeted
26. 26 Targets for Bioadhesive Formulations 1.The eye
The eye is one of the most important and complex organs of the body, because of
its complicated anatomy many things can go wrong with the eye. Topical drug
delivery systems to the eye can be very difficult to achieve because the eye has
several protective mechanisms in place to get rid of foreign substances.
A brief anatomy of the eye
An effective ocular drug delivery system must
be easy to use, comfortable to the patient
and maintain substantial concentrations of
the drug in the eye to produce therapeutic
effects.
27. 27 Some conditions of the eye Conjunctivitis – this is an inflammation of the conjunctivae, which are mucous membranes covering the whites of the eye and the inside of the eyelids. It is caused by bacteria, viruses or allergens and the signs and symptoms displayed by the patient will be dependent on the type of conjunctivitis. The symptoms include: redness of the eye, grittiness or itchy eyes and the presence of a sticky or watery discharge.
Dry eye – this occurs when people don’t have enough tears or the adequate composition of tears required to lubricate the eyes. The occurrence of dry eye increases with age and is therefore common in older people. The eyes become itchy, gritty, painful and have a burning sensation.
Glaucoma – This disorder is characterised by pressure in the eyeballs and causes excessive amounts of aqueous humour (the fluid that fills the eyeballs). This puts pressure on the optic nerves and compresses the blood vessels in the eye. The resultant effects include abnormalities in vision and total blindness.
28. 28 Ocular Bioadhesive Formulations Various ocular bioadhesive formulations have been designed to treat specific
conditions affecting the eye. Such formulations can produce a prolonged or
sustained release of drugs into the eye. Drugs containing polymers attach to the
mucin on the conjunctival surface by means of non-covalent bonding. The polymer
is able to remain in contact with the surface of the eye until mucin replaces itself or
until the pressure of blinking removes the drug from the eye.
EXAMPLES OF PRODUCTS
Hypotears® and Sno Tears® Eye drops are used for dry eye and tear deficiency and they generally lubricate the eyes. They both contain the polymer polyvinyl alcohol (PVA) which increases tear production and protects the eye from further irritation.
The monomer from which
PVA is made
Vinyl alcohol
29. 29 Ocular Bioadhesive Formulations GelTears® and Viscotears® Liquid gel eye drops are used for dry eye conditions and contain carbomer 980 (polyacrylic acid). Carbomers lubricate the eye by clinging to the surface of the eye. This can help reduce the frequency of their application into the eye.
Pilogel® Is an eye gel used in the treatment of glaucoma. It contains the high molecular weight polymer polyacrylic acid. The polymer increases the viscosity of the gel which provides a prolonged retention of the gel in the eye.
POLYACRYLIC ACID
30. 30 Targets for Bioadhesive Formulations 2. The Nasal Cavity
The nasal cavity is the air passage behind the nose. This is the source of the
moisture which is added to air during the breathing process. The nasal cavity has a
complex structure and can become inflamed during conditions such as the common
cold, nasal allergies and flu.
Drugs such as antihistamines and steroids are administered as nasal drops or nasal
sprays to treat conditions affecting the nose. However nasal mucociliary clearance
affects the retention and therefore the effects of the drugs in the nose.
Mucociliary clearance transports mucus from the cells
lining the nose and protects the respiratory tract from
damage caused by inhaled substances including
dirt particles and medicines.
31. 31 Nasal Bioadhesive Formulations By mixing drugs targeted for the nose with bioadhesive polymers, the process of
mucociliary clearance of the drug can be overcome. The effects of bioadhesive
polymers on mucociliary clearance was examined by Zhou and Donovan (1996).
All the polymers examined showed decreases in mucociliary clearance.
Methylcellulose exhibited the most reduction in mucociliary clearance whilst
Carbopol 934P showed the least reduction in mucociliary clearance in the rats used.
EXAMPLES OF PRODUCTS
Rhinocort® Nasal spray is a powdered mixture of the steroid Beclomethasone dipropionate(50µg) and 30mg of Hydroxypropyl cellulose(HPC). Patients suffering from nasal allergy administer one spray twice a day into the nasal cavity.The powder sticks to and swells on the cells lining the nose and remains there until approximately six hours after administration.
32. 32 Nasal Bioadhesive Formulations Beconase® Nasal spray is used to treat nasal inflammation and nasal allergies associated with hayfever. It contains the active ingredient Beclometasone dipropionate and the bioadhesive polymers carboxymethyl cellulose and microcrystalline cellulose.
Nasacort® Nasal spray is used to treat allergies that result in inflammation of the nose. The active ingredient in this product is Triamcinolone acetonide as well as the bioadhesive polymer microcrystalline cellulose. The polymer swells in the presence of water and is able to spread across the nasal mucosa thus helping the distribution of the drug over the mucosal surface.
33. 33 Targets for Bioadhesive Formulations 3. The oral cavity
The oral cavity or the mouth comprises of the cheeks, hard and soft palates and the
tongue. It is an entrance of the digestive system and plays many important
functions which include chewing, speaking and tasting. Some of these functions are
impaired by diseases such as ulcers, microbial infections and inflammation.
Some of the common conditions affecting the oral cavity are discussed on the next
slide.
34. 34 Common conditions affecting the oral cavity Mouth ulcers : A mouth ulcer can be described as a breach or break in the mucous membrane that lines the inside of the mouth. The majority of patients suffer from minor aphthous ulcers (MAU). These ulcers are roundish, shallow, grey-white in colour and are painful. They are small and appear in small crops.
Oral thrush: This is an infection caused by the fungus Candida albicans in the oral cavity. It can also arise due to risk factors such as diabetes, recent antibiotic therapy and inhaled corticosteroids. Oral thrush presents itself as soft creamy-white patches which can be wiped off. The lesions are painful and can occur anywhere in the oral cavity.
Gingivitis: Gingivitis means inflammation of the gums. It is caused by the build-up of plaque (a layer of bacteria) on the teeth. The gums become reddened, swollen and bleed easily with slight trauma such as brushing the teeth.
35. 35 Oral Bioadhesive Formulations Oral bioadhesive formulations are topical products designed to deliver drugs to the
oral cavity which act by adhering to the oral mucosa and therefore produce localised
effects within the mouth.
EXAMPLES OF PRODUCTS
Corlan® Corlan pellets are used in the treatment of mouth ulcers to reduce the
pain, swelling and inflammation associated with mouth ulcers. The active ingredient
of the pellet is Hydrocortisone succinate. It also contains the bioadhesive polymer
Acacia which helps prolong the effect of the drug in the oral cavity. For treatment to
be successful each pellet or lozenge must be allowed to slowly dissolve in the
mouth, close to the ulcer.
36. 36 Oral Bioadhesive Formulations Bonjela® This gel is used in the treatment of the soreness associated with mouth ulcers. The gel is applied over the ulcer every three to four hours or when needed. Bonjela® contains hypromellose 4500 which lubricates the ulcers .
Daktarin® oral gel contains the antifungal agent Miconazole and is used to treat oral thrush. It also contains an adhesive agent known as pregelatinised potato starch which increases the viscosity of the gel and also enables it to stick to the oral mucosa. Patients are advised apply the gel in the mouth and keep it there for as long as possible preferably after food so the gel remains intact for longer.
Corsodyl® oral gel contains the active ingredient chlorhexidine gluconate and is brushed on the teeth to inhibit the formation of plaque and therefore improve oral hygiene. The gel also contains the bioadhesive polymer Hydroxypropyl cellulose(HPC) which helps retain the gel inside the oral cavity.
37. 37 Targets for Bioadhesive Formulations 3a.The Buccal Mucosa
The buccal mucosa refers to the inner lining of the lips and cheeks. The epithelium
of the buccal mucosa is about 40-50 cells thick and the epithelial cells become
flatter as they move from the basal layers to the superficial layers.
The buccal mucosa is less permeable compared to other oral drug delivery
systems and is unable to retain dosage forms at the site of absorption. The
use of bioadhesive polymers in buccal drug delivery systems allows a better
retention of a dosage form by spreading it over the absorption site.
Examples of Products
Buccastem® Is a drug used in the treatment of nausea, vomiting and vertigo. It contains the bioadhesive agents Polyvinylpyrrolidone and Xanthan gum.
Suscard® Is a buccal tablet used in the treatment of angina. It contains the bioadhesive agent Hydroxypropyl methylcellulose (HPMC).
38. 38 Targets for Bioadhesive Formulations 3b. The sublingual mucosa
The sublingual mucosa surrounds the sublingual gland which is a mucin-producing
salivary gland located underneath the tongue.
This mucosa is relatively permeable and gives a rapid absorption of many
drugs due to its excellent blood supply. The sublingual route of drug delivery
is convenient, accessible and generally well accepted by patients.
Drugs administered via the sublingual route are formulated as tablets, powders,
solutions or aerosol sprays. This route is appropriate for many drugs as long
as the drug is able to go into solution with saliva in the mouth.
Examples of sublingual products include Glyceryl Trinitrate (GTN) aerosol spray
and tablet which is administered under the tongue for the prophylactic treatment of
angina.
39. 39 Targets for Bioadhesive Formulations 4.The Skin
The skin is the outer covering of the body and consists of different layers. It
performs several functions which include:
Protecting the body from injury and invasion by pathogens
Preventing the body from becoming dehydrated
Regulating body temperature
Production of Vitamin D Cross section of the skin
40. 40 Topical Bioadhesive Formulations The drug delivery systems used in this case are required to adhere to the skin for
the purpose of:
Collecting body fluids
Protecting the skin
Providing local or systemic drug delivery
Adhesion can be described as the formation of a new mechanical bond between
the skin and the adhesive agent. Bioadhesive products targeted to the skin are
formulated into different dosage forms which include liquids, powders and
semi-solids such as ointments and transdermal patches.
Transdermal patches are sustained-release devices that release a specific amount
of drug whilst firmly attached to the skin. They must provide a firm, soft contact with
the skin but also allow the patch to be easily removed with minor effort.
41. 41 Topical Bioadhesive Formulations Examples of Products
Voltarol® Emulgel: This is a gel which provides a local relief from pain and inflammation in the tendons, muscles and joints. It contains the bioadhesive polymer carbomer which aids the absorption of the active drug by spreading it into the affected area.
Feldene®: This gel is used in the treatment of conditions which are characterised by pain, inflammation and stiffness. The active ingredient in this formulation is piroxicam but the gel also contains two bioadhesive agents to increase its retention at the absorption site. These agents are Carbopol 980 and hydroxyethyl cellulose.
Evorel®: Is a patch used in hormone replacement therapy (HRT) for oestrogen deficiency. It consists of an adhesive matrix through which the active drug (estradiol) is evenly distributed. The adhesive polymers used are guar gum and polyacrylic acid which holds the patch firmly on the skin surface.
42. 42 Targets for Bioadhesive Formulations 5. The Vagina
The vagina is the lower part of the female reproductive tract. It is a muscular tube
lined with mucous membrane which is covered with a layer of stratified squamous
epithelium with an underlying layer of connective tissue (lamina propria) .
Histology of the vaginal mucosa The female reproductive System
43. 43 Common conditions affecting the vagina The epithelium of the vagina contains glycogen, which is broken down enzymes and
bacteria into acids such as lactic acid. This maintains a low vaginal pH which is
normally between 4 and 5.
Such a pH is desirable because it makes the vagina inhospitable to pathogens.
Decreased levels of glycogen in the vagina leads to an increase in vaginal pH and
makes the vagina more susceptible to infection.
Common vaginal infections
Vaginitis : Vaginitis means inflammation of the vagina and it creates discharge, odour, irritation or itching. It has many causes which includes infection with Trichomonas vaginalis, dietary deficiency or poor hygiene.
44. 44 Common conditions affecting the vagina Bacterial vaginosis: The causal organism often implicated in C. albicans
this infection is Gardnerella vaginalis, although other bacteria
present in the vagina also contribute to the cause. The infection
arises due to the overgrowth of these bacteria. About 50% of
patients will have a thin white discharge with a strong fishy odour.
Candidiasis (Thrush): Is a common yeast infection caused
by the organism Candida albicans. The signs and symptoms
of thrush are a white cheesy discharge that itches and irritates
the vagina. T. vaginalis
Trichomoniasis: Is a sexually - transmitted infection caused
by the organism Trichomonas vaginalis. The symptoms in
women include vaginal itching as well as a frothy, foul-smelling,
greenish-yellow discharge.
45. 45 Vaginal bioadhesive formulations The intravaginal route has been used to deliver contraceptives as well as
anti-infective agents such as antifungal drugs to exert a local effect. Agents
targeted for the vaginal route have been formulated into various dosage forms
including creams, gels and vaginal tablets.
Localised application of vaginal formulations enables the spread of these
formulations over the target area, which allows an effective therapy.
Bioadhesive polymers are incorporated into vaginal formulations to aid the
adhering of the dosage form to its target site. Polymers also increase the retention of the active drug in the vagina and also optimises the spread of the formulation over the vaginal epithelium.
46. 46 Vaginal bioadhesive formulations
Table 2: Examples of vaginal
products
47. 47 Targets for Bioadhesive Formulations 6.The Rectum
The rectum is the terminal or end portion of the
gastrointestinal tract. It is an important route
of administration for drugs that have severe
gastrointestinal side effects. This route is also
suitable for patients who cannot take medicines
via the oral route such as unconscious patients
and infants.
The drugs absorbed from the rectum can escape
breakdown by hepatic enzymes. For this reason
mucoadhesive suppositories have been developed
for the local treatment of diseases such as haemorrhoids
and rectal cancer.
48. 48 Rectal Bioadhesive Formulations Bioadhesive polymers are incorporated into rectal suppositories to prolong the
retention of the active drug in the rectum. Prolonged retention in the rectum
increases the chances of reaching a therapeutic outcome.
EXAMPLES OF PRODUCTS
Anacal® Is a rectal ointment used to relieve the symptoms associated with haemorrhoids. It contains the bioadhesive agent polyethylene high polymer 1500.
Germoloids® Is a rectal ointment used to relief the pain, swelling, itchiness and irritation associated with haemorrhoids. It contains the polymer propylene glycol.
Preparation H® Suppositories help shrink the haemorrhoidal tissue which is swollen by irritation. It contains the polymer polyethylene glycol.
49. 49 Summary The concept of bioadhesion involves the binding of a natural or synthetic
bioadhesive polymer to biological substrates such as mucous membranes.
Bioadhesive drug delivery systems have been available since the late 1940s
and have become an important route of delivering drugs.
The earlier applications of bioadhesive formulations mainly involved the oral
cavity and the gastrointestinal tract. These days bioadhesive drug delivery
systems have been developed to target a wider variety of mucosal and epithelial
surfaces, these include the vagina, the skin and the nasal cavity.
In most instances bioadhesive formulations are preferred over the conventional
methods of drug delivery. This is because bioadhesion allows the retention of the
active drug over the mucosal surface and prolongs the contact time between the
polymer and mucosal surface.
Bioadhesive drug delivery also offers a controlled release of drugs. From a
patient’s point of view this is ideal because the frequency of drug administration
is reduced which in turn improves patient compliance.
50. 50 Glossary Angina (angina pectoris): A sense of pain in the centre of the chest which may
spread to the jaws and arms. It may occur as a result of an increase in the demand
of oxygen by the heart.
Basal Layer: Is also known as the basement membrane. It is a thin delicate
membrane that lies at the base of an epithelium and contains connective tissue.
Cellulose: Is a complex carbohydrate consisting of linked glucose units. It is the
primary constituent of plant cell walls.
Epithelium: The tissue that covers the external surface of the body and lines the
inside of the body cavities.
Glycogen: Glycogen is a carbohydrate consisting of branched chains of glucose
units. It is stored in the liver and muscles.
51. 51 Glossary Haemorrhoids: Enlargement of the blood-filled cushions in the wall of the
anus. The anal tissue becomes itchy and painful.
Oestrogen: A hormone that controls female sexual development as well as
promoting the function of the female sex organs.
Progesterone: A steroid hormone responsible for preparing the inner lining of the
uterus for pregnancy.
Prophylactic: An agent that prevents the development of a condition or disease.
Spermicidal contraceptive: An agent that kills mature male sex cells.
Stratified squamous: Refers to a type of epithelium which consists of one or more
cell layers. The cells are flat and scale-like in nature.
Vertigo: A sensation of dizziness or a confused, disorientated state of mind.
52. 52 Useful Links www.answers.com/
www.bnf.org
http://www.drugdeliverytech.com
http://www.drugdeliverytech.com/cgi-bin/articles.cgi?idArticle=159
www.medicines.org.uk
http://www.netdoctor.co.uk/
53. 53 Quiz Question 1.
Which one of the following is NOT a natural polymer?
a) Acacia gum
b) Tragacanth
c) Carbomer
d) Alginic Acid
54. 54 Question 2.
What is the primary constituent of mucus?
a) Water
b) Glycoproteins
c) Inorganic salts
d) Fats
55. 55 Question 3.
The structure on the right represents:
a )Cellulose
b) Pectin
c) Tragacanth
d) Polyacrylic acid
56. 56 Question 4.
The only types of bonds formed between polymer chains and
biological substrates are hydrogen bonds and Van der Waals forces.
a) True
b) False
57. 57 Question 5.
Which of the following best describes the order of bioadhesion?
a) Spreading, bond formation and penetration
b) Bond formation, swelling and absorption
c) Swelling, interpenetration and bond formation
d) Swelling, interpenetration and absorption
58. 58 Question 6.
The biological polymer sodium hyaluronate is used in ocular drug delivery
systems and contains repeating units of:
a) Glucosamine
b) Glucose
c) Glycogen
d) Glucagon
59. 59 Question 7.
The buccal mucosa is the most permeable route of drug delivery within the
oral cavity.
a) True
b) False
60. 60 Question 8.
Zidoval® contains the bioadhesive agent carbomer and is used to treat:
a) Candidiasis
b) Vaginitis
c) Bacterial vaginosis
d) Vaginal atrophy
61. 61 Question 9.
Which of the following gels contain pregelatinised potato starch as its
bioadhesive agent?
a) Feldene®
b) Corsodyl®
c) Pilogel®
d) Daktarin®
62. 62 Question 10.
Mucociliary clearance in the nose is increased by the presence of bioadhesive
polymers.
a) True
b) False
63. 63
64. 64
65. 65
66. 66
67. 67
68. 68
69. 69
70. 70
71. 71
72. 72
73. 73
74. 74
75. 75
76. 76
77. 77
78. 78
79. 79
80. 80
81. 81
82. 82
83. 83
84. 84
85. 85
86. 86
87. 87
88. 88
89. 89
90. 90
91. 91
92. 92
93. 93
94. 94
95. 95
96. 96
97. 97 END OF QUIZ